Natural killer activity in stage III and IV endometriosis
Advanced stage endometriosis is associated with decreased natural killer cell activity, inversely related to serum estradiol levels, but these cells remain responsive to lymphokine stimulation in vitro.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (21)
- Decreased Natural Killer Cell Activity in Women with Endometriosis via openalex
- Deficient cellular immunity in endometriosis via openalex
- Etiology and epidemiology of endometriosis via openalex
- Immunologic Aspects of Human Endometriosis via openalex
- Immunosuppressive activity of peritoneal fluid in women with endometriosis. via openalex
- Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity. via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Suppression of natural killer cell activity by sera from patients with endometriosis via openalex
- W2063847873 via openalex
- W2314331148 via openalex
- W2400534755 via openalex
- W2477008945 via openalex
- W141728048 via openalex
- W4313313358 via openalex
- W1549355081 via openalex
- W1961969217 via openalex
- W1977468032 via openalex
- W2003300271 via openalex
- W2017220207 via openalex
- W2020153990 via openalex
- W2020525068 via openalex
Cited by (27)
- Neuroinflammation is responsible for pain in endometriosis - targeting the JAK-STAT pathway and mast cell activation 2025
- Soluble MICA in endometriosis pathophysiology: Impairs NK cell degranulation and effector functions 2024
- Changes in the number and activity of natural killer cells and its clinical association with endometriosis: systematic review and meta-analysis 2024
- TIM‐3 Expression in Endometriosis 2024
- Myeloid-derived suppressor cells: A new emerging player in endometriosis 2023
- The pathogenesis of endometriosis: clues from the immunological evidence 2021
- NK Cells as Potential Targets for Immunotherapy in Endometriosis 2019
- Patients With Endometriosis of the Rectosigmoid Have a Higher Percentage of Natural Killer Cells in Peripheral Blood 2012
- Treatment of Endometriosis with Transvaginal Ultrasound-Guided Drainage and Recombinant Interleukin-2 Left in the Cysts: A Third Clinical Trial 2009
- Interleukin-2 receptor gene C627T polymorphism in Korean women with endometriosis: a case-control study 2009
- Targeting Mast Cells in Endometriosis with Janus Kinase 3 Inhibitor, JANEX‐1 2007
- The estimation of IL-2 and IL-2 receptors in peritoneal fluid of infertile patients with endometriosis 2007
- Efficacy of imiquimod, an immunomodulatory agent, on experimental endometriosis 2007
- The endometria of patients with endometriosis show higher expression of class I human leukocyte antigen than the endometria of healthy women 2006
- Emerging drugs in endometriosis 2006
- Decreased peritoneal concentrations of interleukin-15 in women with advanced stage endometriosis 2006
- Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage, and intracystic recombinant interleukin-2 2005
- Interleukin-2 receptor β (IL-2Rβ)-627*C homozygote but not IL-12Rβ1 codon 378 or IL-18 105 polymorphism is associated with higher susceptibility to endometriosis 2005
- Natural Approaches to Relieving Endometriosis 2005
- Treatment of Endometriosis with Transvaginal Ultrasound-Guided Drainage under GnRH Analogues and Recombinant Interleukin-2 Left in the Cysts 2005
- In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis 2004
- GnRH Analogues, Transvaginal Ultrasound-Guided Drainage and Intracystic Injection of Recombinant Interleukin-2 in the Treatment of Endometriosis 2003
- Immunology of endometriosis 2002
- 10.1016/s1047-9422(03)00073-7 2000
- Induction of Endometriosis and Adenomyosis by Transvaginal Pituitary Transplantation in Mice with and without Natural Killer Cell Activity 1998
- IMMUNOLOGY AND ENDOMETRIOSIS 1997
- Natural cytotoxicity and gnrh agonist administration in advanced endometriosis: positive modulation on natural killer activity 1996
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:11:13.665691+00:00